References
- Antoch G, Saoudi N, Kuehl H, et al: Accuracy of wholebody dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDGPET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 22:4357-4368 (2004) https://doi.org/10.1200/JCO.2004.08.120
- Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK: PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 225:575-581 (2002) https://doi.org/10.1148/radiol.2252011568
- Lardinois D, Weder W, Hany TF, et al: Staging of nonsmall-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500-2507 (2003) https://doi.org/10.1056/NEJMoa022136
- Lee JH, Kim JS: A Case of Incidentally Detected nasopharyngeal Tuberculosis on F-18 FDG PET/CT. Nucl Med Mol Imaging 42:482-484 (2008)
-
Lee HJ, Jeong JM, Lee YS, et al: Quality control of residual solvents in [
$^{18}$ F]FDG preparations by gas chromatography. Nucl Med Mol Imaging 41:566-569 (2007) - Hung JC: Comparison of various requirements of the quality assurance procedures for (18)F-FDG injection. J Nucl Med 43:1495-1506 (2002)
- Son HK, Kim HJ, Jung HJ, et al: A study of quality control of nuclear medicine counting system and gamma camera. Korean J Med Phys 12:103-112 (2001)
- IAEA International atomic energy agency, quality assurance for radioactivity measurement in nuclear medicine. IAEA technical reports series No.454, IAEA, Vienna (2006)
- Taylor JR: An introduction to error analysis: the study of uncertainties in physical measurements. University Science Books, Sausalito, CA (1999), pp. 128-129 (1999)
- Ryu JS: Evaluation of cancer treatment using FDG-PET. Korean J Nucl Med 36:64-73 (2002)
- Nguyen XC, Lee WW, Sung SW, et al: Prognostic usefulness of maximum standardized uptake value on FDG-PET in surgically resected non-small-cell lung cancer. Nucl Med Mol Imaging 40:205-210 (2006)
- Lowe VJ, Kim H, Boyd JH, Eisenbeis JF, Dunphy FR, Fletcher JW: Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET imaging. Radiology 212:799-802 (1999)
- Hubner KF, Thie JA, Smith GT, Chan AC, Fernandez PS, McCoy JM: Clinical utility of FDG-PET in detecting head and neck tumors; a comparison of diagnostic methods and modalities. Clinical Positron Imaging 3:7-16 (2000) https://doi.org/10.1016/S1095-0397(99)00112-0
- Rege S, Safa AA, Chaiken L, Hoh C, Juillard G, Withers HR: Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomas. Am J Clin Oncol 23:164-169 (2000) https://doi.org/10.1097/00000421-200004000-00012
- O'Farrell C, Zimmer1 M, McDonald N, Spies S: Accuracy of the F-18 calibration setting with a Capintec dose calibrator. J Nucl Med 49(Suppl 1):435 (2008)
- Mo L, Reinhard MI, Davies JB, Alexiev D, Baldock C: Calibration of the Capintec CRC-712M dose calibrator for (18)F. Appl Radiat Isot 64:485-489 (2006) https://doi.org/10.1016/j.apradiso.2005.09.006
- Dansereau RN, Methe BM: Dose variance associated with calibration and administration of radiopharmaceuticals. Am J Health Syst Pharm 58:580-584 (2001)
- Lee BI: Quality assurance and performance evaluation of PET/CT. Nucl Med Mol Imaging 42:137-144 (2008)
- European Pharmacopoeia, European directorate for the quality of medicines. 4. EDQM, Strasbourg (2001)